ATLANTA, Oct. 10 (UPI) -- One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said.
LONDON, July 18 (UPI) -- British drug giant GlaxoSmithKline said Wednesday its cervical cancer vaccine candidate Cervarix has been recommended for approval in Europe.
PERTH, Australia, June 28 (UPI) -- Australian scientists said an international study has proven a new vaccine provides broad protection against cervical cancer.
PHILADELPHIA, June 28 (UPI) -- GlaxoSmithKline said Thursday an analysis of data from a phase 3 trial shows its cervical cancer vaccine protects against most virus types.
LOS ANGELES, April 17 (UPI) -- British-based global drug giant GlaxoSmithKline said Tuesday its human papillomavirus vaccine Cervarix shows 100 percent efficacy against the deadliest HPV.
PHILADELPHIA, Jan. 18 (UPI) -- GlaxoSmithKline said Thursday it launched a head-to-head U.S. study of its cervical cancer vaccine Cervarix versus Merck's Gardasil.
LONDON, Sept. 4 (UPI) -- British health officials are being told that vaccinating all 12-year-old girls to prevent cervical cancer could save more than 700 lives a year.
BIRMINGHAM, England, Dec. 4 (UPI) -- New research into the body's immune response to the human papilloma virus (HPV) could lead to a vaccine against cervical cancer, a study said.
NEW YORK, April 7 (UPI) -- A new experimental vaccine can reduce the risk of cervical cancer by 90 percent, a study says.
LONDON, Oct. 29 (UPI) -- British researchers say a vaccine against cervical cancer could be available within three years, the BBC reported Friday.
